antiviral

Merck’s antiviral pill reduces hospitalization of Covid patients
News

Merck’s antiviral pill reduces hospitalization of Covid patients

An investigational antiviral pill reduced the chances that patients newly diagnosed with Covid-19 would be hospitalized by about 50%, a finding that could give doctors a desperately needed new way to treat the sick, the drug maker Merck announced Friday. A five-day course of molnupiravir, developed by Merck and Ridgeback Biotherapeutics, reduced both hospitalization and […]

Read More